Program Profile

Beyond Medicines in Ukraine

Improve access and affordability to diagnostic procedures for patients with relapsed and refractory Hodgkin’s lymphoma in Ukraine.

The CD30 and PET-CT scans needed for diagnosis of lymphoma are unaffordable for some patients in Ukraine.

The objectives of the program are to:

  • Improve access to diagnostic procedures for relapsed and refractory Hodgkin’s lymphoma patients
  • Support the ongoing professional development of pathologists and clinicians who diagnose and treat lymphoma

The program covers the costs for PET-CT scans, an expensive diagnostic procedure that is not covered by the government or health insurance. It also covers the costs of immuno-histochemistry which is a valuable clinical tool for assessing CD30+ patients who may respond to treatments such as Adcetris® that target the CD30 protein. In addition, the program also provides professional development of pathologists, through our partner, National Cancer Institute of Ukraine:

  • Seminars to discuss difficult diagnostic cases, which in turn strengthen inks between pathologists and clinicians
  • Provision of web-based resources for pathologists
  • Hodgkin’s lymphoma tutorials for clinicians in the major cities of Ukraine

Since the launch of the program (September 2016) approximately 200 PET-CT scan tests and 300 CD30+ tests have been subsidized. Through this initiative approximately 100 pathologists have been trained and more than 200 nurses trained with six nursing programs delivered in major cities across the Ukraine.

The data for this program has been reviewed by both the companies and the Access Observatory team.